Patients in their reproductive age group should use an effective method of birth control; patients who are breast-feeding, or have a positive pregnancy test will be excluded from the study
Patients who are breastfeeding, pregnant or refuse to use an effective form of birth control are excluded; abstinence is considered an effective form of birth control
Subjects of reproductive potential who are not willing to employ effective birth control from screening to  year after last dose of vaccine
Subjects who are pregnant, breast feeding or sexually active and unwilling to use effective birth control while on treatment with TKI
Patients who are pregnant, breast-feeding, or unwilling to practice an effective method of birth control
Women of childbearing potential (WOCBP) who are pregnant or lactating or unwilling to use  forms of effective birth control
Women who are breast feeding, or have a positive pregnancy test (reproductive age should use effective birth control during study if randomized to SBRT treatment arm)
Effective birth control should be utilized as indicated
Patients who are pregnant, breast feeding, or if sexually active and unwilling to use effective birth control for the duration of this study will be excluded
Subjects in their reproductive age group should use an effective method of birth control; subjects who are breast-feeding, or have a positive pregnancy test will be excluded from the study
Female patients who are pregnant or breast feeding, or adults who are of reproductive potential and are unwilling to refrain from conceiving a child during study treatment
Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study
Pregnant and/or lactating women will be excluded; premenopausal patients will undergo pregnancy testing when indicated; women will practice effective birth control while receiving protocol treatment
Any women who are pregnant or breast feeding, or women/men able to conceive and unwilling to practice an effective method of birth control
Pregnancy or nursing or unwilling to take adequate birth control during therapy; NOTE: breastfeeding should be discontinued
Patients must not be pregnant, lactating, or unwilling to use birth control
Pregnant and lactating women are excluded from this study; women of reproductive potential that are not using or are unwilling to use effective birth control methods throughout the trial are excluded
Patients that are pregnant, breast feeding, or unwilling to use effective contraception during the study
Female subject who is pregnant, breastfeeding, or if of child bearing potential is unwilling to practice birth control until  years following surgery.
Pregnancy or nursing or unwilling to take adequate birth control during therapy
Women who are pregnant or breast feeding. Adults of reproductive potential not employing two forms of birth control as per Pregnancy Prevention Risk Management Plan.
Patients who are breastfeeding, pregnant or refuse to use an effective form of birth control are excluded; abstinence is considered an effective form of birth control
Participants must use effective birth control throughout study until at least  days after study treatment or  year after rituximab treatment, whichever is later; female participants must not be pregnant or breast-feeding
Women who are pregnant or breast-feeding and women or men not practicing effective birth control
Female patients who are pregnant or breast feeding, or adults of reproductive potential who are not using barrier birth control methods, are not eligible for participation
Females who are pregnant or breast-feeding during the study period will be excluded; adults of reproductive potential not employing an effective method of birth control will be excluded; sexually active women of child bearing potential, whose partner is male, must use medically accepted birth control; sexually active men, whose partner is a female of childbearing potential, must use a medically accepted birth control
Pregnant or breast feeding women, or women of child-bearing potential (and/or their partners) who are unwilling to utilize an approved method of birth control during the study and for  month afterward
Women who are pregnant or breast-feeding and women or men not practicing effective birth control
Females who are pregnant or need to breast feed during the study period will be excluded; patients found to be pregnant will be excluded; male and female enrolled patients will be advised to practice an effective method of birth control
Subjects who are pregnant, breast feeding or sexually active and unwilling to use effective birth control for the duration of the study.
The patient is pregnant or unwilling to practice appropriate birth control
Not pregnant, not lactating, and agree to use effective birth control
Pregnant or breastfeeding women and adults of reproductive potential not employing an effective method of birth control are excluded from this study
Patients who are known or thought to be sexually active must use effective birth control.**
If female patient with reproductive capacity: on effective means of barrier birth control during the entire duration of the treatment
Pregnant women are ineligible, as treatment involves unforeseeable risks to the embryo or fetus; female patients with reproductive capacity are required to use effective means of birth control during the entire duration of the treatment
Pregnant or able to become pregnant and unwilling to use two forms of birth control during the study period
Pregnant, or had given birth, or nursed at any time during the last  months
Women who are pregnant or breast feeding. Adults of reproductive potential not willing to employ two forms of birth control.
Are pregnant, breastfeeding, or unwilling to practice an acceptable form of birth control during the study.
